暂无数据
暂无内容
暂无数据
暂无数据
暂无数据
快讯 | Matinas BioPharma将于2024年5月9日通过网络直播电话会议讨论2024年第一季度的财务业绩,并提供业务最新情况
Reuters07:00 (美东)
发表在《抗微生物药物与化疗杂志》上的 Matinas BioPharma 口服 MAT2203 对肺毛霉病的体内疗效
对中性粒细胞减少小鼠模型的研究表明,存活时间延长,真菌负担减轻,肺部感染有所改善。新泽西州贝德明斯特,2024年4月30日(GLOBE NEWSWIRE)— Matinas Bi
GlobeNewswire04/30 08:00 (美东)
快讯 | Matinas BioPharma Holdings Inc:联盟全球合作伙伴以买入评级和0.6美元的目标价启动保险
Reuters04/26 08:51 (美东)
Matinas BioPharma的数百万股出售和封锁协议
TipRanks04/05 07:12 (美东)
快讯 | Matinas BioPharma将1000万美元的注册直接发行定价,合并发行价为每股0.30美元,附带认股权证
Moomoo 24/704/03 08:34 (美东)
Matinas BioPharma定价1000万美元的注册直接发行
新泽西州贝德明斯特,2024年4月3日(GLOBE NEWSWIRE)——Matinas BioPharma Holdings, Inc.(纽约证券交易所代码:MTNB)(“Matinas BioPharma” 或 “公司”),一家临床阶段的生物制药公司,专注于提供突破性成果
GlobeNewswire04/03 08:30 (美东)
Deutsche Trader : You moved from a stock with a 900k float to one with a 200 million float horrible choice
Sm1sm楼主 Deutsche Trader: Earn what I needed, then jump the ship.
Sm1sm楼主 :
NVFY then 4, now 3.9
MTNB then 0.34, now 0.4
you decide which is horrible
Deutsche Trader : MTNB is .32 not .4 chart doesn’t look good and neither does share structure so I’ll pass.. staying in NVFY
Sm1sm楼主 Deutsche Trader:
I'm not staying with penny stocks. Btw I read about MTNB success in a clinical programme. one of the reasons I bought it.
Good luck. Will surely rejoin if
暂无数据
暂无数据
Jaguar8 : We need this medication. Alert to shorters!
Trytosaveabit楼主 Jaguar8: Yes sir 100% correct! But you really think that most SS’s give two s*its! As long as they make a few bucks who cares if they have to bankrupt a company doing great things for so many in need! Sad but true my friend
Jaguar8 Trytosaveabit楼主: I know and they will suffer the wrath of karma
Trytosaveabit楼主 Jaguar8: Yup